While many M&A pros fear that the slew of health care laws and regulations that took hold during President Barrack Obama's presidency may chill dealmaking, there is a silver lining, says Steven Gerst of investment bank StillPoint Capital LLC. New regulations, such as the 2.3 percent excise tax on medical devices that went into effect on Jan. 1, may worry some private equity and strategic buyers. However, both the medical device and health care information technology (IT) sectors continue to be a vibrant playing field for buyers due to hospitals and private practices being mandated to invest in new technologies, such as electronic medical record systems, Gerst explains. We caught up with Gerst at the recent Alliance of Merger & Acquisition Advisors' (AM&AA) Summer Conference in Chicago. A health care IT specialist, Gerst is also a vice president at clinical decision software provider MedCurrent Corp. and senior vice president of MZI Healthcare LLC.
How is the new health care law affecting deal flow?